Market Tracker

10/01 6:05pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

1.42
Data as of Oct 01
 -0.01 / -0.70%
Today’s Change
1.10
Today|||52-Week Range
2.14
-27.55%
Year-to-Date

Today’s Trading

Previous close1.43
Today’s open1.42
Day’s range1.41 - 1.44
Volume1,216,202
Average volume (3 months)1,589,488
Market cap$375.9M
Dividend yield--
Data as of 3:59pm ET, 10/01/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+11.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.32-3.68%
PGNXProgenics Pharmaceut...-0.20-3.85%
VVUSVIVUS Inc-0.11-2.85%
SCLNSciClone Pharmaceuti...0.000.00%
Data as of 4:14pm ET, 10/01/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts